# Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction

> **NCT06565728** · PHASE1 · COMPLETED · sponsor: **Cairo University** · enrollment: 99 (actual)

## Conditions studied

- Fetal Growth Retardation

## Interventions

- **DRUG:** Vitamin D3 2000 UNT Oral Tablet

## Key facts

- **NCT ID:** NCT06565728
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-03
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-06
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06565728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06565728, "Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06565728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*